CIS and Russia

CIS and Russia has strong potential for growth in the pharma industry despite the lack of clarity and vagueness of regulation. Russia alone has a market size of approximately USD 15.3 billion and has a growth forecast of 15%.

ELC has strategically partnered with local experts who have many years of experience in the local market and regulations. They are constantly updated with the latest changes and is aware of the upcoming changes. Within ELC's Business Development and Project Management teams, Russian speakers are present to ensure a smooth communication between the Health Agencies and clients.

Services

Clinical Trials

Pharmaceutical Registration

We can provide selected resources and support as you undertake procedures, or manage the entire cycle from the compilation of application forms through to obtaining marketing authorization.

Pharmacovigilance

Market Access

  • Distributor Search
  • Local Company Representative
  • Company Registration